Skip to main content

Advertisement

Log in

Ethical Principles for Psychiatric Administrators: The Challenge of Formularies

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Rising costs continue to plague healthcare and mental healthcare. The latest variation of managed care techniques has been to try to reduce medication costs by instituting formulary restrictions. To date, the results have been spotty at best, with a suggestion of a ballooning of more general mental healthcare costs, as well as possibly worsening of quality of care. New challenges are looming in terms of the results of the CATIE study comparing typical and atypical antipsychotic medication, as well as the beginning of Medicare D medication coverage. In the midst of the uncertainty and complexity, the psychiatrist administrator has the ethical challenge and chance to make a major difference. By keeping the well-being of patients first, but also addressing the needs of the institution, payor, and other stakeholders, the psychiatrist administrator can ethically find ways to reduce costs and increase quality. One such product could be medication algorithms that also incorporate costs, side effects, and general healthcare.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sabin JE, Daniels N, Teagarden JR: The perfect storm. Psychiatric Annals 34:125–132, 2004.

    Google Scholar 

  2. Tennison CR: Responding to restrictive formularies. Psychiatric Annals 34:139–148, 2005.

    Google Scholar 

  3. Moffic HS: Managed behavioral healthcare poses multiple ethical challenges for clinicians. Psychiatric Annals 34:98–104, 2004.

    Google Scholar 

  4. American Psychiatric Association: The Principles of Medical Ethics with Annotations Especially Applicable to Psychiatry. Washington, DC, American Psychiatric Association, 2001.

    Google Scholar 

  5. Moffic HS: Ethical Principles for Psychiatric Administrators. American Association of Psychiatric Administrators Newsletter Summer:5–9, 2000.

    Google Scholar 

  6. Starkweather KK, Shon SP: Implementing Medication Algorithms: The Texas Experience. Psychiatrist Administrator 1(1):13–18, 2001.

    Google Scholar 

  7. Moffic HS: The Ethical Way: Challenges and Solutions for Managed Behavioral Healthcare. San Francisco, Jossey-Bass, 1997.

    Google Scholar 

  8. American Psychiatric Association Office of Healthcare Systems and Financing: Fail-First Policies – The Tip of the Pharmacy Benefit Management Iceberg 8(506):1&19, 20, 2002.

    Google Scholar 

  9. Sabin JE, Daniels N: Improving Psychiatric Drug Benefit Management: II. Kaiser Permanente's Approach to SSRI's. Psychiatric Services 54:1343–349, 2003.

    Article  PubMed  Google Scholar 

  10. Sullivan PW, Valuck R, Brixner DJ, et al: Managed Care's Response to a Pharmacoeconomic Model of Serotonin Reuptake Inhibitors. P&T 30:178–182, 2005.

    Google Scholar 

  11. Kanapaux W: Managed to hold down medicaid drug costs. Behavioral Healthcare Tomorrow April:22–29, 2005.

    Google Scholar 

  12. New Jersey Psychiatric Association: Consensus and Evidence Based Guidelines for Psychotropics in Formularies. http://www.psychnj.org/, May 10, 2005.

  13. Ingoglia CS: Caring for persons with mental illness: making policy decisions that are truly cost-effective. Drug Benefit Trends Supplement 15:5–11, 2003.

    Google Scholar 

  14. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al: Effects of limiting medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine 331:650–655, 1994.

    Article  PubMed  CAS  Google Scholar 

  15. Frieden J: Psychiatric Formularies Not Likely to Save Money. Clinical Psychiatry News December:64, 2003.

    Google Scholar 

  16. Cranor CW, Bunting BA, Christensen DB: The Ashville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. Journal of the American Pharmaceutical Association 43:149–159, 2003.

    Article  PubMed  Google Scholar 

  17. Wassef AA, Winkler DE, Roche AL, et al: Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions. American Journal of Psychiatry 162:330–339, 2005.

    Article  PubMed  Google Scholar 

  18. Ning A, Dubin WR, Parks JJ: Pharmacy costs: Finding a role for quality. Psychiatric Services 56:909–911, 2005.

    Article  PubMed  Google Scholar 

  19. Lieberman JA, Stroup TS, McEvoy JP, et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353:1209–23, 2005.

    Article  PubMed  CAS  Google Scholar 

  20. Keefe RSE, Seidman LJ, Christensen BK: Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. American Journal of Psychiatry 161:985–995, 2004.

    Article  PubMed  Google Scholar 

  21. Stahl SM: Detecting and dealing with bias in psychopharmacology. PsychEd Up 1(4):6, 2005.

    Google Scholar 

  22. Baker JG: Engaging community mental health stakeholders in pharmacy cost management. Psychiatric Services 52:650–653, 2001.

    Article  PubMed  CAS  Google Scholar 

  23. Siris SG: Minding my own business. Psychiatric Services 56:1339, 2005.

    Article  PubMed  Google Scholar 

  24. Fawcett J: What we need is living treatment algorithms. Psychiatric Annals 35:873, 2005.

    Google Scholar 

  25. Horn S: Limiting access to psychiatric services can increase total health care costs. Drug Benefit Trends Supplement 15:12–18, 2003.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Steven Moffic M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moffic, H.S. Ethical Principles for Psychiatric Administrators: The Challenge of Formularies. Psychiatr Q 77, 319–327 (2006). https://doi.org/10.1007/s11126-006-9017-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-006-9017-8

Keywords

Navigation